Ranolazine

NDC 72578-065 · Viona Pharmaceuticals Inc

Generic nameRanolazine

Dosage formTABLET, EXTENDED RELEASE

RouteORAL

Active ingredient(s)RANOLAZINE

Strength1000 mg/1

Pharmacologic classAnti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]

Marketing categoryANDA

Packages

72578-065-01 — 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-065-01)

72578-065-05 — 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-065-05)

72578-065-14 — 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72578-065-14)

72578-065-77 — 10 BLISTER PACK in 1 CARTON (72578-065-77) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (72578-065-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70625-207 — RANOLAZINE, 70756-703 — Ranolazine, 70756-704 — Ranolazine, 70771-1499 — Ranolazine, 70771-1500 — Ranolazine, 71205-867 — Ranolazine, 71205-868 — Ranolazine, 71335-2556 — RANOLAZINE, 71610-518 — RANOLAZINE, 71610-971 — RANOLAZINE, 72319-021 — RANOLAZINE, 72319-022 — RANOLAZINE, 72578-064 — Ranolazine, 73141-021 — RANOLAZINE, 73141-022 — RANOLAZINE, 77771-423 — RANOLAZINE, 77771-424 — RANOLAZINE, 82804-118 — Ranolazine, 90096-151 — ranolazine, 90096-152 — ranolazine, +34 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.